top of page

Google’s AI-Designed Drugs Head to Human Trials

  • Writer: Nikita Silaech
    Nikita Silaech
  • Jul 8
  • 1 min read
ree

Google DeepMind’s spin‑out Isomorphic Labs is preparing to launch its first human clinical trials for drugs fully designed by AI. Leveraging breakthroughs like AlphaFold, the startup aims to revolutionize drug discovery by reducing time and cost while improving success rates in areas such as cancer.

Why this matters for Responsible AI:

  • Safety & ethics at the forefront: Clinical trials involve high-stakes decisions—governance, transparency, and accountability in AI medicine are non-negotiable.

  • SMB lessons: Companies adopting AI in life sciences will need robust frameworks for risk assessment, auditability, and compliance.

  • RAIF’s perspective: As AI transforms healthcare, we’re here to guide organizations—especially SMBs—through ethical deployment. From validation protocols to bias mitigation and explainability, our tools and consulting ensure AI serves humanity responsibly.


Source: NDTV

Comments

bottom of page